Gå direkt till innehåll

Kategorier: typ-1 diabetes

  • Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes

    Forxiga is the first oral medicine recommended for approval in Europe
    as an adjunct treatment to insulin for adults with type-1 diabetes
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a new indication for the marketing authorisation of Forxiga (dapagliflozin), after adopting a positive opinion for use as an oral adjunct treat